Head to head
McGraw Hill vs New Oriental
Side-by-side on the measures that matter, with a plain-English read. Full detail: MH · EDU
MH
McGraw Hill
12.05+1.95%
1-year price shape — -28% over the period
Quant Rating D · 15/100
vs
EDU
New Oriental
51.03-2.98%
1-year price shape — +0% over the period
Quant Rating D · 40/100
1-year performance, rebased to 100
New Oriental edges it on the scoreable measures. New Oriental has the highest Quant Rating (40); New Oriental has done best over the past year (+0%); New Oriental pays the highest dividend yield.
| MH | EDU | |
|---|---|---|
| Snapshot | ||
| Sector | -- | -- |
| Last price | 12.05 | 51.03 |
| Change today | +1.95% | -2.98% |
| 1-year return | -27.5% | +0.4% |
| Market cap | $2.31B | $7.90B |
| 52-week range | 8.95 – 18.00 | 43.42 – 63.02 |
| Valuation | ||
| P/E (TTM) | -48.59 | 15.95 |
| P/E percentile, own 5-yr range | 0th | 34th |
| P/B | 2.63 | 1.86 |
| Dividend yield | 0.00% | 2.35% |
| Profitability & growth | ||
| EPS (TTM) | 0.19 | 3.00 |
| Net profit (TTM) | $35.40M | $464.72M |
| Revenue (TTM) | $2.08B | $6.01B |
| Provider revenue period date | 2026-09-29 | 2026-08-30 |
| Revenue growth (YoY) | -5.5% | +23.1% |
| Gross margin | 81.7% | 54.3% |
| Operating margin | 15.3% | 11.8% |
| Net margin | 3.5% | 8.4% |
| Free cash flow (TTM) | $112.45M | $783.25M |
| Provider cash-flow period date | 2026-09-29 | 2026-08-30 |
| Ownership & sentiment | ||
| Institutional ownership | 101.9% | 67.3% |
| Insider activity (12mo) | 23 buy / 0 sell | 0 buy / 5 sell |
| Short interest (% of float) | 1.4% | 1.6% |
| Analyst consensus | 88% buy / 12% hold (8) | 100% buy (3) |
| Analyst price target | $16 (+35%) | $77 (+52%) |
| StockVane view | ||
| StockVane Quant Rating | D (15) | D (40) |
| Company | ||
| Employees | 4,400 | 88,372 |
| Founded | 1888 | 1993 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.